Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections
| Status: | Recruiting |
|---|---|
| Conditions: | Ocular |
| Therapuetic Areas: | Ophthalmology |
| Healthy: | No |
| Age Range: | 50 - Any |
| Updated: | 2/23/2019 |
| Start Date: | October 30, 2018 |
| End Date: | June 9, 2020 |
| Contact: | Novartis Pharmaceuticals |
| Email: | novartis.email@novartis.com |
| Phone: | 1-888-669-6682 |
A Multicenter, Randomized, Double-masked Phase 3a Study to Assess Safety and Efficacy of Brolucizumab 6 mg q4 Weeks Compared to Aflibercept 2 mg q4 Weeks in Patients With Neovascular Age-related Macular Degeneration (nAMD) With Persistent Retinal Fluid (MERLIN)
The purpose of this study is to compare safety and efficacy of brolucizumab 6 mg dosed every
4 weeks to aflibercept 2 mg dosed every 4 weeks in those nAMD patients with retinal fluid
despite frequent anti-Vascular Endothelial Growth Factor (VEGF) injections.
4 weeks to aflibercept 2 mg dosed every 4 weeks in those nAMD patients with retinal fluid
despite frequent anti-Vascular Endothelial Growth Factor (VEGF) injections.
Inclusion Criteria:
- Sign informed consent
- Diagnosis of wet age-related macular degeneration (AMD)
- Currently receiving anti-VEGF injections
Exclusion Criteria:
- Active infection or inflammation in either eye
- Significant fibrosis in the study eye
- Recent ocular surgery
- Uncontrolled glaucoma
- Previous treatment with brolucizumab in the study eye
- Use of medications as specified in the protocol
- Pregnant, nursing
- Of child-bearing potential unless using highly effective method of contraception
Other protocol-defined inclusion/exclusion criteria may apply
We found this trial at
39
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Novartis Novartis, which was created in 1996 by the merger of the Swiss companies Ciba-Geigy...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials